CytomX Therapeutics, Inc. 4
4 · CytomX Therapeutics, Inc. · Filed Jan 25, 2016
Insider Transaction Report
Form 4
Kavanaugh William Michael
CSO, Head Res.&Non-Clin. Dev.
Transactions
- Award
Employee Stock Option (right to buy)
2016-01-21+80,000→ 80,000 totalExercise: $14.46Exp: 2026-01-20→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]This option vests in 48 substantially equal monthly installments starting on January 1, 2016.